At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
nitroglycerin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Nov 26, 2013
In Brief
A Phase 3 clinical trial evaluating nitroglycerin, streptokinase, and 1 other intervention for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To assess the effect of non-surgical reperfusion on infarct size in patients with acute myocardial infarction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
1982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 1982
Study CompletionOct 1987
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartAug 1, 1982
Study CompletionOct 1, 1987
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
nitroglycerindrug
streptokinasedrug
heart catheterizationprocedure